Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1126
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.03B
| $8.96M | 0.01% |
306,000
-18,257
| -6% | -$519K |
2024 Q3
3 quarters
|
|
1127
Revolution Medicines
RVMD
$40.7B
| $8.96M | 0.01% |
243,504
+100,700
| +71% | +$3.87M |
2025 Q1
1 quarter
|
|
1128
NuScale Power
SMR
$2.95B
| $8.96M | 0.01% |
+226,400
| New | +$5.68M |
2025 Q2
0 quarters
|
|
1129
TaskUs
TASK
$746M
| $8.96M | 0.01% |
534,323
+73,500
| +16% | +$1.12M |
2022 Q3
11 quarters
|
|
1130
Gulfport Energy Corp
GPOR
$2.88B
| $8.95M | 0.01% |
44,500
+28,100
| +171% | +$5.24M |
2024 Q2
4 quarters
|
|
1131
Arvinas
ARVN
$500M
| $8.94M | 0.01% |
1,214,355
+1,082,055
| +818% | +$7.97M |
2023 Q1
9 quarters
|
|
1132
Ibotta
IBTA
$868M
| $8.93M | 0.01% |
244,000
+162,300
| +199% | +$7.58M |
2024 Q2
4 quarters
|
|
1133
FIGS
FIGS
$2.62B
| $8.9M | 0.01% |
1,577,300
+951,847
| +152% | +$4.39M |
2022 Q1
13 quarters
|
|
1134
AMN Healthcare
AMN
$1.41B
| $8.89M | 0.01% |
430,200
-45,610
| -10% | -$948K |
2024 Q3
3 quarters
|
|
1135
Orrstown Financial Services
ORRF
$804M
| $8.88M | 0.01% |
278,946
+15,000
| +6% | +$444K |
2013 Q2
48 quarters
|
|
1136
Napco Security Technologies
NSSC
$1.29B
| $8.87M | 0.01% |
298,800
+45,700
| +18% | +$1.18M |
2024 Q1
5 quarters
|
|
1137
ProShares Bitcoin Strategy ETF
BITO
$1.67B
| $8.86M | 0.01% |
+411,800
| New | +$8.49M |
2025 Q2
0 quarters
|
|
1138
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.98B
| $8.86M | 0.01% |
364,854
-48,046
| -12% | -$1.16M |
2023 Q4
6 quarters
|
|
1139
BrightSpring Health Services
BTSG
$12.6B
| $8.79M | 0.01% |
372,700
-292,700
| -44% | -$6.11M |
2024 Q1
5 quarters
|
|
1140
NEOS Nasdaq 100 High Income ETF
QQQI
$15.1B
| $8.79M | 0.01% |
+169,000
| New | +$8.28M |
2025 Q2
0 quarters
|
|
|
FARO
1141
DELISTED
Faro Technologies
FARO
| $8.79M | 0.01% |
200,042
+125,700
| +169% | +$4.6M |
2022 Q3
11 quarters
|
|
|
CVGW
1142
DELISTED
Calavo Growers
CVGW
| $8.76M | 0.01% |
329,474
+38,754
| +13% | +$1.01M |
2017 Q3
31 quarters
|
|
1143
General Dynamics
GD
$89.6B
| $8.75M | 0.01% |
30,000
-255,900
| -90% | -$70.4M |
2025 Q1
1 quarter
|
|
1144
Vaxcyte
PCVX
$10.6B
| $8.75M | 0.01% |
269,077
+72,800
| +37% | +$2.39M |
2024 Q4
2 quarters
|
|
1145
Paysign
PAYS
$868M
| $8.74M | 0.01% |
1,213,896
-61,006
| -5% | -$218K |
2019 Q2
24 quarters
|
|
1146
Affiliated Managers Group
AMG
$10B
| $8.74M | 0.01% |
44,400
-2,600
| -6% | -$451K |
2022 Q1
13 quarters
|
|
1147
Laureate Education
LAUR
$5.44B
| $8.72M | 0.01% |
372,800
+74,500
| +25% | +$1.6M |
2020 Q1
21 quarters
|
|
1148
Gaotu Techedu
GOTU
$646M
| $8.71M | 0.01% |
2,414,000
-400
| -0% | -$1.37K |
2021 Q3
15 quarters
|
|
1149
Regency Centers
REG
$13.2B
| $8.71M | 0.01% |
122,323
-261,500
| -68% | -$18.7M |
2021 Q2
16 quarters
|
|
1150
Natural Gas Services Group
NGS
$427M
| $8.71M | 0.01% |
337,342
-26,400
| -7% | -$593K |
2013 Q2
48 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.